Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
The association of KEAP1 and NFE2L2 polymorphisms with glycemic control and late complications in patients with type 2 diabetes
ID
Vraničar, Zala
(
Author
),
ID
Goričar, Katja
(
Author
),
ID
Blagus, Tanja
(
Author
),
ID
Dolžan, Vita
(
Author
),
ID
Klen, Jasna
(
Author
)
PDF - Presentation file,
Download
(753,66 KB)
MD5: 5EF28AFDFB56794E9086ECBD2AD530D8
URL - Source URL, Visit
https://www.sciencedirect.com/science/article/pii/S0378111925004202
Image galllery
Abstract
To investigate the association of KEAP1 rs1048290, rs9676881 and NFE2L2 rs6706649, rs6721961, rs35652124 polymorphisms with glycemic control and development of late complications in patients with type 2 diabetes mellitus (T2DM), a total of 316 T2DM patients were included in the retrospective genetic association study. Genotyping was performed using competitive allele-specific PCR. Data on HbA1c levels as a measure of glycemic control, and information on late complications, including ischemic heart disease, retinopathy, and nephropathy, was obtained from the medical records. Logistic regression analysis was used to assess the association between selected genetic polymorphisms and patients outcomes. Significant associations were observed between KEAP1 rs9676881 (p < 0.001) and NFE2L2 rs6721961 (p = 0.006) polymorphisms and elevated HbA1c levels. Additionally, NFE2L2 rs35652124 polymorphism was linked to a nominally higher risk of late complications, including ischemic heart disease (p = 0.036), retinopathy (p = 0.032), and nephropathy (p = 0.026). Results indicate that polymorphisms in the KEAP1 and NFE2L2 genes may influence glycemic control and the development of late complications in T2DM patients. These findings provide valuable insights into the genetic factors underlying T2DM progression and its complications in European populations, highlighting the potential role of genetic markers in optimizing personalized treatment strategies.
Language:
English
Keywords:
diabetes mellitus type 2
,
oxidative pathway
,
genetic polymorphism
,
microvascular complications
,
macrovascular complications
,
personalized medicine
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
BF - Biotechnical Faculty
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
7 str.
Numbering:
Vol. 964, art. 149631
PID:
20.500.12556/RUL-182545
UDC:
616.3
ISSN on article:
1879-0038
DOI:
10.1016/j.gene.2025.149631
COBISS.SI-ID:
240248579
Publication date in RUL:
15.05.2026
Views:
171
Downloads:
149
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Gene
Shortened title:
Gene
Publisher:
Elsevier
ISSN:
1879-0038
COBISS.SI-ID:
23394309
Licences
License:
CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:
http://creativecommons.org/licenses/by-nc/4.0/
Description:
A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0298
Name:
Geni, hormonske in osebnostne spremembe pri metabolnih motnjah
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back